News Headlines Article

Pharmacists call for delay on new Medicaid generic reimbursement rates
Modern Healthcare

Pharmacists and drug manufacturers are pushing the CMS for a one-year transition period before states attempt to implement a new formula mandated under the Patient Protection and Affordable Care Act that will significantly trim Medicaid reimbursement rates for generic drugs.

Last August, HHS‘ Office of the Inspector General compared existing state Medicaid programs’ generic prescription reimbursement limits with the new limits mandated by the ACA and found that on average, the new federal reimbursement limits are 22% below the current state amounts and could save Medicaid up to $1.2 billion per year.